Operations

Karenann Terrell appointed Chief Digital & Technology Officer, GSK

July 25, 2017

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Karenann Terrell has been appointed Chief Digital & Technology Officer with a company-wide remit to transform how new technologies are used to improve performance across the Group. Karenann will join GSK on 4 September and will be a member of the Corporate Executive Team (CET). In this new […]

RedHill Biopharma Reports 2017 Second Quarter Financial Results

July 25, 2017

TEL-AVIV, Israel and RALEIGH, N.C., July 25, 2017 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today reported its financial results for the quarter […]

Amicus Therapeutics to Announce Second Quarter 2017 Financial Results on August 7, 2017

July 25, 2017

CRANBURY, N.J., July 25, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on August 7, 2017 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2017. The call will be hosted by John F. Crowley, Chairman and Chief Executive Officer. He […]

Achaogen Wins CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant Infections

July 25, 2017

SOUTH SAN FRANCISCO, Calif., July 25, 2017 (GLOBE NEWSWIRE) — Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced a collaboration with CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a global public-private partnership focused on funding the development of promising new antibiotics and rapid diagnostics. CARB-X […]

PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results

July 25, 2017

SOUTH PLAINFIELD, N.J., July 25, 2017 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter financial results and provide an update on the company’s business and outlook on Tuesday, August 8, 2017 at 4:30 p.m. (ET) after the closing of the […]

Gemphire Enters Into $15 Million Term Loan Agreement With Silicon Valley Bank

July 25, 2017

LIVONIA, Mich., July 25, 2017 (GLOBE NEWSWIRE) — Gemphire Therapeutics Inc. (NASDAQ:GEMP) today announced that it has entered into a loan and security agreement with Silicon Valley Bank for a term loan of up to $15 million, subject to funding in up to three tranches. Gemphire immediately drew $10 million upon execution of the loan […]

Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics

July 25, 2017

NORCROSS, Ga., July 25, 2017 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has received notice of allowance for a U.S. Patent for “Method of Enhancing Specific Immunotherapies in Cancer Treatment.” Cancer immunotherapy research conducted by Dr. William Redmond at the Earle […]

Razorfish Health Announces the Promotion of Keri Hettel to SVP, Analytics and Strategy and Brandon Ashcraft to SVP, Operations

July 25, 2017

July 25, 2017, PHILADELPHIA — Razorfish Health, a uniquely-integrated health and wellness advertising agency, announces the promotion of Keri Hettel to SVP, Analytics and Strategy, and Brandon Ashcraft to SVP, Operations. These new roles for Hettel and Ashcraft mark the agency’s commitment to meeting their growing client needs. Both report directly to David Paragamian, Managing […]

Discovery Worldwide Names Rico Ricketson as Head of Client Services

July 24, 2017

July 24, 2017, Philadelphia — Discovery Worldwide, a healthcare communications agency that combines the power of science, storytelling and innovative delivery to move health forward, announces the appointment of Rico Ricketson as Head of Client Services. Ricketson is charged with developing and leading client services teams that consult with healthcare brands to build commercial solutions […]

VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer

July 24, 2017

GAITHERSBURG, Md., July 21, 2017 /PRNewswire/ — VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the appointment of Jacob Licht as Chief Operating Officer.   Mr. Licht comes to VLP Therapeutics with nearly 20 years of business development and strategy […]

Merrimack Appoints Thomas Needham as Chief Business Officer

July 24, 2017

CAMBRIDGE, Mass., July 24, 2017 /PRNewswire/ — Merrimack Pharmaceuticals (NASDAQ: MACK) today announced further expansion of its executive management team with the appointment of Thomas E. Needham, Jr., M.B.A., to the position of Chief Business Officer. In this role, Mr. Needham will help design and implement Merrimack’s strategy for its broad pipeline of clinical and […]

Compugen Second Quarter 2017 Conference Call Scheduled for Wednesday, August 2, 2017 at 10:00 AM ET

July 24, 2017

HOLON, Israel, July 24, 2017 /PRNewswire/ —   Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery company, announced today that the Company will release its second quarter financial results on Wednesday, August 2, 2017 before the U.S. financial markets open. Management will host a live webcast to review the results and provide a corporate update at […]

eFFECTOR Therapeutics Completes $38.6 Million Series C Financing

July 24, 2017

SAN DIEGO, July 24, 2017 /PRNewswire/ — eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators for the treatment of cancer, today announced that the company has raised $38.6M in Series C financing. Pfizer Venture Investments (PVI) led the round and was joined by additional new investors including Alexandria Venture Investments. All […]

ArQule To Report Second Quarter 2017 Financial Results On August 4, 2017

July 24, 2017

BURLINGTON, Mass.–(BUSINESS WIRE)–ArQule, Inc. (Nasdaq: ARQL) today announced it will report financial results for the second quarter 2017 before the market opens on Friday, August 4, 2017. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update.   […]

Cerus to Release Second Quarter 2017 Results on August 3, 2017

July 24, 2017

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, August 3, 2017, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the Company’s financial results and provide a general […]

Tissue Regenix Announces Proposed Acquisition of CellRight Technologies

July 24, 2017

SAN ANTONIO–(BUSINESS WIRE)–Tissue Regenix, the UK-based regenerative medical devices company, today announced the proposed acquisition of CellRight Technologies, a U.S. regenerative medicine company based in San Antonio, TX. This acquisition would bring together two highly complementary technology and product platforms focused on soft-tissue regeneration and regenerative bone matrices, respectively.   “We are combining two highly […]

Concert Pharmaceuticals Announces Termination of the HSR Act Waiting Period for CTP-656 Asset Purchase Agreement with Vertex

July 24, 2017

LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Federal Trade Commission (“FTC”) has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) for the pending sale of CTP-656 and other assets related to the treatment of cystic fibrosis by Concert to Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX). […]

Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President of Corporate Development and Strategy

July 24, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced the appointment of Deborah Palestrant, Ph.D., MBA, to Vice President of Corporate Development and Strategy. Palestrant brings to Relay significant life sciences industry experience including drug discovery, company creation, operations, business development, and strategy.   […]

United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017

July 24, 2017

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 21, 2017 /PRNewswire/ — United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2017 financial results before the market opens on Thursday, July 27, 2017. United Therapeutics will host a teleconference on Thursday, July 27, 2017, at 9:00 a.m. Eastern Time. […]

BriaCell Expands Targeted Pipeline via Acquisition of Sapientia Pharmaceuticals

July 24, 2017

BERKELEY, CA and VANCOUVER, BC–(Marketwired – July 24, 2017) – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX VENTURE: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary vaccine technology, is pleased to announce that it has entered into a definitive share exchange agreement (the “Share Exchange Agreement”) with its wholly-owned subsidiary, BriaCell […]

Cancer Immunotherapy Company Vaxil Appoints Dr. Terry Plasse as Chief Medical Officer

July 24, 2017

TORONTO, ON and REHOVOT, ISRAEL–(Marketwired – July 24, 2017) – VAXIL BIO LTD. (TSX VENTURE: VXL), an Israeli-Canadian biotech developing innovative immunotherapy treatments for cancer, is pleased to announce the appointment of Dr. Terry Plasse as its Chief Medical Officer, responsible for the Company’s clinical program surrounding its drug candidate, ImMucin™. Dr. Plasse brings 30 […]

Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO

July 24, 2017

OTTAWA, ONTARIO–(Marketwired – July 24, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017. Mr. Andre Rancourt, previous interim CEO will take the position as Chairman of […]

Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman’s Diagnostics and Treatment Segment

July 24, 2017

TORONTO, ON–(Marketwired – Jul 24, 2017) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman’s diagnostics and treatment segment products. Easton has closed on its agreement with Alliance Group and has acquired 45 acres of agriculturally zoned land north […]

Ablynx Announces Warrant Exercise

July 24, 2017

GHENT, Belgium, 24 July 2017 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 19.833 common shares have been issued by the Company in exchange for €121.444 as the result of the […]

NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in Cash

July 24, 2017

REHOVOT, Israel, July 24, 2017 (GLOBE NEWSWIRE) — NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that it has signed a definitive agreement under which Mitsubishi Tanabe Pharma Corporation (TSE Code:4508) (“MTPC”), a publicly traded company on the Tokyo Stock Exchange, will acquire NeuroDerm […]

Cytovance® Biologics Inc. Completes Its First FDA General Inspection Of Oklahoma City, OK Facilities

July 24, 2017

OKLAHOMA CITY, July 24, 2017 (GLOBE NEWSWIRE) — Cytovance hosted an unannounced FDA inspection Tuesday, July 11th 2017. The inspector conducted the inspection over an eight day period and focused on Quality Systems. Overall the inspection was very positive and the inspector acknowledged that the site had already identified and taken action on most of […]

Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

July 24, 2017

RANCHO CUCAMONGA, Calif., July 24, 2017 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that a federal jury delivered a unanimous verdict in favor of Amphastar in a lawsuit brought by Momenta Pharmaceuticals, Inc. and Sandoz Inc. (the “Plaintiffs”) in the U.S. Court for the District of Massachusetts. The jury found the claims of […]

BioCryst to Announce Second Quarter 2017 Financial Results on August 7

July 24, 2017

RESEARCH TRIANGLE PARK, N.C., July 24, 2017 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that its second quarter 2017 financial results will be reported on Monday, August 7, 2017. BioCryst will host a conference call and webcast at 11:00 a.m. Eastern Time to discuss financial results and to provide an update regarding the […]

ZIOPHARM Oncology to Host Second-Quarter 2017 Financial Results and Corporate Update Conference Call on July 31, 2017 at 4:30 p.m. ET

July 24, 2017

BOSTON, July 24, 2017 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that it will host a conference call and webcast slide presentation on Monday, July 31, 2017 at 4:30 p.m. ET to provide a corporate update and discuss financial results for the second quarter ended June […]

FEEDBACK